Senokot Max Strength tablets Adult

Țară: Regatul Unit

Limbă: engleză

Sursă: MHRA (Medicines & Healthcare Products Regulatory Agency)

Ingredient activ:

Senna fruit

Disponibil de la:

Reckitt Benckiser Healthcare (UK) Ltd

Codul ATC:

A06AB06

INN (nume internaţional):

Senna fruit

Dozare:

15mg

Forma farmaceutică:

Oral tablet

Calea de administrare:

Oral

Clasă:

No Controlled Drug Status

Tip de prescriptie medicala:

Valid as a prescribable product

Rezumat produs:

BNF: 01060200; GTIN: 5011417577349

Prospect

CUSTOMER INFO:
Minimum Point Size =
9.00pt
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
BARCODE INFO
Barcode Type:
Barcode Number:
Magnification:
Truncated By:
Full Height:
Bar Height (Smallest Bar):
BWR:
Encoded Data:
Trident Reference No:
ZEN Ref:
Action:
Brand:
Category:
Segment Group:
Segment:
Pack Size:
Market/Country:
Date:
Component Code
(2D if applicable)
:
2
nd
Component Code
(if applicable)
:
Parent Technical Packaging Specification:
Finished Goods Code:
Supply Point:
3rd Party Code
Pharmacode No/NE:
Edgemark Position:
CAD Cam Ref:
Printer:
Substrate:
N/A
N/A
RB Hull
NA
0000000
Senokot
Stimulant Laxative
Senna
Max Strength Tablet
12x10Pack
RB485401
Please note that any low resolution paper Canon colour copies
associated with this job should be referred to for content, layout
and colour separation only.
STUDIO USE ONLY
v2.0
Sm•Art check results:
Cutter
Guides
Technical & Non Printing Items
Cutter 2 (if applicable)
Guides 2 (if applicable)
Multi Packaging Solutions (Tewkesbury, UK)
Skt-Lft-D8372157-160mmx250mm
TR2259993
Paper White
UK
12/08/21
A
balaji haridass
0000000
N/A
G=2; O=0; R=0; - BH - 12/08/21 21:24:01
RB Artwork and
Print Specification
D8372157
Artwork Type:
BW Submission
10
mm
20
30
40
50
60
70
80
90
100
110
120
130
140
150
160
170
180
190
200
210
220
230
240
250
1
LTH
PANTONE 347 C
Colours (Leaflet)
RBH Contact:
Alexander Titmus
Connaught House, Connaught Road,
Kingswood Business Park, Hull, HU7 3AP, England.
T: [phone]
UNDER NO CIRCUMSTANCES SHOULD THIS
ARTWORK BE ALTERED WITHOUT PRIOR
PERMISSION FROM TRIDENT.
PACKAGE LEAFLET: INFORMATION FOR THE USER
SENOKOT MAX STRENGTH TABLETS ADULT
SENNA FRUIT (PODS)
READ THIS LEAFLET CAREFULLY BECAUSE IT CONTAINS IMPORTANT INFORMATION
FOR YOU.
• Keep this leaflet. You may need to read it again.
• Ask your pharmacist if you need more information or advice.
• Always take this medicine exactly as described in this leaflet or
as your doctor or pharmacist have told you.
• If any of the side effects get serious or if you notice any side
effects

Caracteristicilor produsului

1
NAME OF THE MEDICINAL PRODUCT
Senokot Max Strength Tablets Adult.
2.
QUALITATIVE AND QUANTITATIVE COMPOSITION
Each tablet contains powdered Alexandrian Senna fruit (pods) (_Cassia
senna _L._ _(_C. _
_acutifolia _Delile)) and Tinnevelly Senna fruit (pods) (_Cassia
angustifolia _Vahl)
equivalent to 15mg hydroxyanthracene glycosides, calculated as
sennoside B.
Each tablet also contains 31.64 mg lactose monohydrate
For full list of excipients see Section 6.1.
3
PHARMACEUTICAL FORM
Tablets.
4.1
THERAPEUTIC INDICATIONS
For the short-term relief of occasional constipation.
4.2
POSOLOGY AND METHOD OF ADMINISTRATION
For oral use only.
_Dosage _
Adults, the elderly and children over 18 years: 1 tablet taken at
night.
Should not be used in children or adolescents under the age of 18
years.
_Duration of use _
Not to be used for more than 1 week. Usually it is sufficient to take
this medicinal
product up to two to three times during that week.
If the symptoms persist during the use of the medicinal product, a
doctor or a
pharmacist should be consulted.
See also section 4.4 Special warnings and precautions for use.
4.3
CONTRAINDICATIONS
Hypersensitivity to the active substance or to any of the excipients.
Not to be used at the same time as other laxative agents.
Cases of intestinal obstructions and stenosis, atony, appendicitis,
inflammatory
colon diseases (e.g Crohn’s disease, ulcerative colitis), abdominal
pain of unknown
origin, severe dehydration state with water and electrolyte depletion.
Children and adolescents under 18 years of age.
4.4
SPECIAL WARNINGS AND PRECAUTIONS FOR USE
If the symptoms worsen during the use of the medicinal product, or
there is no bowel
movement after three days, a doctor or pharmacist should be consulted.
The product contains lactose monohydrate. One tablet contains 31.64 mg
lactose
monohydrate. Patients with rare hereditary problems of galactose
intolerance, the
Lapp lactase deficiency or glucose-galactose malabsorption should not
take this
medicine.
Do not exceed the stated dose.
Patients